Formulation Development Center

Syngene’s FDC offers an integrated, end-to-end pathway for oral small-molecule drug products, spanning discovery, pharmaceutics and solid-state form selection through phase-appropriate GMP manufacturing, analytical lifecycle management, and late-stage scale-up through to commercial manufacturing.

With co-located Drug Substance (DS), Drug Product (DP), and Analytical teams, supported by digital quality systems and a strong global inspection track record, we enable seamless collaboration across functions. This integrated model helps reduce development risk, strengthen data continuity, and accelerate key milestones from first-in-human (FIH) studies through pivotal development and beyond.